Progressive increase of T1 signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images in the pediatric brain exposed to multiple doses of gadolinium contrast

Brain and Development

Volumn 38, Issue 3, 2016, Pages 331-336

  Roberts, Donna R ^a   Holden, Kenton R ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Gadolinium based contrast agent (GBCA); MRI; Safety

Indexed keywords

CONTRAST MEDIUM; GADOLINIUM; GADOLINIUM PENTETATE MEGLUMINE;

ADOLESCENT; ARTICLE; BIOACCUMULATION; BLOOD BRAIN BARRIER; BRAIN DEVELOPMENT; CASE REPORT; DENTATE NUCLEUS; DRUG EXPOSURE; FEMALE; GLOBUS PALLIDUS; HUMAN; KIDNEY FUNCTION; NUCLEAR MAGNETIC RESONANCE IMAGING; SIGNAL PROCESSING; ADVERSE EFFECTS; BONE; CEREBELLUM NUCLEUS; METABOLISM; PATHOLOGY; PHYSIOLOGY; RETROSPECTIVE STUDY;

ADOLESCENT; BLOOD-BRAIN BARRIER; BONE AND BONES; CEREBELLAR NUCLEI; CONTRAST MEDIA; FEMALE; GADOLINIUM; GLOBUS PALLIDUS; HUMANS; MAGNETIC RESONANCE IMAGING; RETROSPECTIVE STUDIES;

EID: 84958117665     PISSN: 03877604     EISSN: 18727131     Source Type: Journal    
DOI: 10.1016/j.braindev.2015.08.009     Document Type: Article

References (11)

1. Errante Y., Cirimele V., Mallio C.A., Di Lazzaro V., Zobel B.B., Quattrocchi C.C. Progressive increase of T1 signal intensity of the dentate nucleus on unenhanced magnetic resonance images is associated with cumulative doses of intravenously administered gadodiamide in patients with normal renal function, suggesting dechelation. Invest Radiol 2014, 49:685-690.
2. Kanda T., Ishii K., Kawaguchi H., Kitajima K., Takenaka D. High signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images: relationship with increasing cumulative dose of a gadolinium-based contrast material. Radiology 2014, 270:834-841.
3. Kanda T., Osawa M., Oba H., Toyoda K., Kotoku J., Haruyama T., et al. High signal intensity in dentate nucleus on unenhanced T1-weighted MR images: association with linear versus macrocyclic gadolinium chelate administration. Radiology 2015, 275:803-809.
4. Quattrocchi C.C., Mallio C.A., Errante Y., Cirimele V., Carideo L., Ax A., et al. Gadodiamide and dentate nucleus T1 hyperintensity in patients with meningioma evaluated by multiple follow-up contrast-enhanced magnetic resonance examinations with no systemic interval therapy. Invest Radiol 2015, 50:470-472.
5. Radbruch A., Weberling L.D., Kieslich P.J., Eidel O., Burth S., Kickingereder P., et al. Gadolinium retention in the dentate nucleus and globus pallidus is dependent on the class of contrast agent. Radiology 2015, 275:783-791.
6. McDonald R.J., McDonald J.S., Kallmes D.F., Jentoft M.E., Murray D.L., Thielen K.R., et al. Intracranial gadolinium deposition after contrast-enhanced MR imaging. Radiology 2015, 275:772-782.
7. Kanda T., Fukusato T., Matsuda M., Toyoda K., Oba H., Kotoku J., et al. Gadolinium-based contrast agent accumulates in the brain even in subjects without severe renal dysfunction: evaluation of autopsy brain specimens with inductively coupled plasma mass spectroscopy. Radiology 2015, 276:228-232.
8. Port M., Idee J.M., Medina C., Robic C., Sabatou M., Corot C. Efficiency, thermodynamic and kinetic stability of marketed gadolinium chelates and their possible clinical consequences: a critical review. Biometals 2008, 21:469-490.
9. White G.W., Gibby W.A., Tweedle M.F. Comparison of Gd(DTPA-BMA) (Omniscan) versus Gd(HP-DO3A) (ProHance) relative to gadolinium retention in human bone tissue by inductively coupled plasma mass spectroscopy. Invest Radiol 2006, 41:272-278.
10. Blakemore S.J. Imaging brain development: the adolescent brain. Neuroimage 2012, 61:397-406.
11. Stein J., Schettler T., Wallinga D., Valenti M. In harm's way: toxic threats to child development. J Dev Behav Pediatr 2002, 23:S13-S22.